|
65 APPG inquiry appeals to pharmacists for evidence Ordinary
pharmacists have been encouraged to tell the All-Party Pharmacy Group
what they think the future of pharmacy should hold
PJ 2006;277:65
Full Text
65 Concern mounts
over job security in PCTs Pharmacists and other head office
staff in primary care trusts across England are facing uncertainty over
their futures in the run up to the reorganisation of PCTs
PJ 2006;277:65
Full Text
65 Unscheduled care payments
announced in Scotland Community pharmacists in Scotland are to receive funding in recognition of the pressures they face in the out-of-hours period.
An overall sum had been promised as part of the new pharmacy contract deal and
this week it was announced how the sum will be distributed among contractors
PJ 2006;277:65
Full Text
66 NPA
concerned about 100-hour exemption abuse Concerns about exploitation
of the 100-hour exemption rule under NHS pharmacy control of entry reforms have
been raised by the National Pharmacy Association
PJ 2006;277:66
Full Text
66 Section 60 threatens
professional support Plans for the future regulation of pharmacy by the Royal Pharmaceutical Society will lead to a reduction in the Society's professional and supportive roles. This is the view of the Institute of Pharmacy Management International set out in its response to the Government's consultation on the proposed Section 60 Order
PJ 2006;277:66
Full Text
66 New oxygen suppliers
may not meet 1 August deadline Some pharmacists may still be required
to dispense oxygen after 1 August, when the formal transition period to the new
service arrangements ends, the Pharmaceutical Services Negotiating Committee
said this week
PJ 2006;277:66
Full Text
66 AAH training programme AAH
Pharmaceuticals is to offer a training programme for preregistration graduates
from October
PJ 2006;277:66
Full Text
66 Preregistration information NHS boards in Scotland are being asked by the Scottish Executive to provide information about pharmacy preregistration places within their board area. Details required include the names of students, locations of placements and level of funding provided by boards to community pharmacy contractors
PJ 2006;277:66
Full Text
66 Numark's practice diary Numark
has launched a professional practice diary for its members to help them record
learning activities that happen within their day-to-day work
PJ 2006;277:66
Full Text
67 MPs
say NPSA has not improved safety enough Insufficient progress has
been made in improving safety in the NHS over the past few years, according to
a new parliamentary report
PJ 2006;277:67
Full Text
67 Financial failures
of NHS trusts share common causes Financial failure of NHS trusts
cannot be separated from wider organisational failures, an Audit Commission report
has concluded
PJ 2006;277:67
Full Text
67 Regular paracetamol
may reduce ovarian cancer risk, but further studies are needed Regular paracetamol use is associated with a 30 per cent reduction in risk of developing ovarian cancer, according to the authors of a meta-analysis published in the British
Journal of Clinical Pharmacology. However, they warn that the association cannot yet be regarded as one that should prompt a public health recommendation
PJ 2006;277:67
Full Text
68 Latest
medicines assessed by SMC all accepted Tigecycline (Tygacil) has been
accepted for restricted use within NHS Scotland in the latest round of recommendations
released by the Scottish Medicines Consortium
PJ 2006;277:68
Full Text
68 Additional safety information
issued for infliximab Additional safety information for the tumour
necrosis factor inhibitor infliximab (Remicade) has been released by the drug's
manufacturer
PJ 2006;277:68
Full Text
68 Children’s persistent
coughs may be pertussis Almost 40 per cent of school children in
the UK who visit their GP with a persistent cough have evidence of whooping cough
infection, even though they have been immunised, a study has revealed
PJ 2006;277:68
Full Text
68 No strong evidence
to favour any one drug for Bell’s palsy No firm conclusions
can be drawn about the benefit of any single drug for the treatment of Bell's
palsy, the Drug and Therapeutics Bulletin says in its July issue
PJ 2006;277:68
Full Text
R&D news
69 More
quit smoking with new drug than bupropion Varenicline, a partial agonist
of the a4b2 nicotinic acetylcholine receptor, is better at helping people to
stop smoking and to stay abstinent than both placebo and bupropion SR, according
to three studies conducted by the Varenicline Phase 3 Study Group
PJ 2006;277:69
Full Text
69 Genetic variation linked
with improved response to beta-blocker, say researchers Researchers
have identified a polymorphism that is associated with an improved response to
beta-blockers in heart failure
PJ 2006;277:69
Full Text
70 Abatacept
continues to show benefits for rheumatoid arthritis Positive results
continue to emerge for abatacept, the first in a new class of drugs for rheumatoid
arthritis that selectively modulates the co-stimulatory signal required for full
T-cell activation. A study suggests that abatacept reduces disease activity in
patients with rheumatoid arthritis who have had an inadequate response to methotrexate
PJ 2006;277:70
Full Text
70 Novel targeted approach
for prostate cancer tested A new, targeted RNA therapy has been shown
to be effective in a mouse model of prostate cancer, according to research published
online
PJ 2006;277:70
Full Text
|
The
Pharmaceutical Journal